Author:
Smart Alicia C.,Goyal Lipika,Horick Nora,Petkovska Natasa,Zhu Andrew X.,Ferrone Cristina R.,Tanabe Kenneth K.,Allen Jill N.,Drapek Lorraine C.,Qadan Motaz,Murphy Janet E.,Eyler Christine E.,Ryan David P.,Hong Theodore S.,Wo Jennifer Y.
Funder
DF/HCC SPORE in Gastrointestinal Cancer
NIH Rare Cancer Genetics Registry
Publisher
Springer Science and Business Media LLC
Reference17 articles.
1. Altekruse SF, Devesa SS, Dickie LA, McGlynn KA, Kleiner DE. Histological classification of liver and intrahepatic bile duct cancers in SEER registries. J Registry Manag. 2011;38:201–5.
2. Bujold A, Massey CA, Kim JJ, Brierley J, Cho C, Wong RKS, et al. Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. J Clin Oncol. 2013;31:1631–9.
3. Gkika E, Hallauer L, Kirste S, Adebahr S, Bartl N, Neeff HP, et al. Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma. BMC Cancer. 2017;17:781.
4. Hong TS, Wo JY, Yeap BY, Ben-Josef E, McDonnell EI, Blaszkowsky LS, et al. Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol. 2016;34:460–8.
5. Jackson MW, Amini A, Jones BL, Rusthoven CG, Schefter TE, Goodman KA. Treatment selection and survival outcomes with and without radiation for unresectable, localized intrahepatic cholangiocarcinoma. Cancer J. 2016;22:237–42.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献